Sajjad Akhtar, MD
Ophthalmology · Astoria, NYNPI 1912919457
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $285,000 of the $293,838 with a category attached, or 97.0%. Alcon accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $149,614 and has fallen 100.0% since, to $57 in 2025. Among ophthalmology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $16,324 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$294K
- AstraZeneca$57
What the payments were for
- Consulting fees$285,00097%
- Travel & lodging$7,6973%
- Food & beverage$1,1410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 17 | $293,781 |
| AstraZeneca | 1 | $57 |
How this compares
$293,838 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 256 | $142,696 |
| LumiganBimatoprost | 78 | $41,071 |
| CombiganBrimonidine Tartrate/Timolol | 128 | $25,655 |
| Brimonidine Tartrate | 139 | $25,062 |
| Prednisolone Acetate | 242 | $16,362 |
| RhopressaNetarsudil Mesylate | 40 | $12,124 |
| Cyclosporine | 43 | $9,439 |
| Latanoprost | 1,203 | $7,426 |
| RocklatanNetarsudil Mesylat/Latanoprost | 15 | $4,779 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 340 | $4,576 |
| Ketorolac Tromethamine | 114 | $3,558 |
| Ofloxacin | 147 | $3,237 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 32 | $3,000 |
| Azelastine Hcl | 163 | $2,103 |
| Bromfenac Sodium | 15 | $1,979 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Astoria
- David RubaltelliBrooklyn$8.9M
- Nathan RadcliffeNew York$2.1M
- Richard SpaideNew York$1.7M
- Eric DonnenfeldGarden City$1.4M
- Marguerite McDonaldOceanside$893K
- Joshua YoungNew York$814K
- David KleinmanRochester$730K
- Jonathan JonischGreat Neck$726K
- Joseph PanarelliNew York$541K
- Eric RosenbergNew York$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.